Skip to main content
. Author manuscript; available in PMC: 2019 Aug 21.
Published in final edited form as: J Urol. 2008 Aug 20;180(4 Suppl):1700–1704. doi: 10.1016/j.juro.2008.03.117

Table 1:

Characteristics of the study groups:

Characteristic Congenital urological anomaly (n=35) Other diagnoses (n=57) p-value Statistical test used

Age (years)
Mean (SD)
14.1 (1.86) 14.0 (2.08) 0.85 t-test

Child Sex (%male) 27 (77.1%) 33 (57.9%) 0.06 Chi squared test

Parent Sex
(% female)
29 (82.9%) 47 (82.46%) 0.96 Chi-squared test

Biological parent (%) 32 (91.4%) 54 (94.7%) 0.67 Fisher’s exact test

Parent race (% white) 31 (88.6%) 32 (57.1%) 0.002 Fisher’s exact test

Hematocrit
Mean (SD)
34.0 (4.29) 34.6 (5.42) 0.62 t-test

Transplant (%) 22 (62.9%) 31 (54.4%) 0.43 Chi-squared test

CRF (%) 13 (37.1%) 26 (45.6%) 0.43 Chi-squared test

Albumin
Mean (SD)
4.1 (0.38) 4.1 (0.50) 0.70 t-test

CKD Stage (%)
   Stage I 3 (10%) 12 (21.4%) 0.06 Fisher’s exact test
   Stage II 10 (33.3%) 19 (33.9%)
   Stage III 14 (46.7%) 14 (25%)
   Stage IV 1 (3.33%) 10 (17.9%)
   Stage V 2 (6.7%) 1 (1.8%)